pH Pharma Co. Revenue and Competitors
Estimated Revenue & Valuation
- pH Pharma Co.'s estimated annual revenue is currently $15.3M per year.
- pH Pharma Co.'s estimated revenue per employee is $155,000
Employee Data
- pH Pharma Co. has 99 Employees.
- pH Pharma Co. grew their employee count by -10% last year.
pH Pharma Co.'s People
| Name | Title | Email/Phone |
|---|
pH Pharma Co. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is pH Pharma Co.?
pH Pharma's vision is focused on developing innovative healthcare products for high unmet clinical and consumer needs. Our aspiration is to drive innovative cross-border transactions, transparent management, and engine for developing future leaders. ?pH? is a numeric scale used to specify the acidity or alkalinity of an aqueous solutions. We will utilize our scientific and business judgment to decide on investment criteria and to construct a balanced portfolio of innovative healthcare technologies/products.
keywords:N/A
N/A
Total Funding
99
Number of Employees
$15.3M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
pH Pharma Co. News
Moreover, the BOI is actively promoting the Philippines as a manufacturing hub for pharmaceutical companies to produce Covid-19 medicines...
Bryan Mazlish, co-founder and CEO, set out why the technology is ... as well as the omicron variant by fall, CEO Albert Bourla, Ph.D.,...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.8M | 99 | 125% | $252M |
#2 | $32.7M | 99 | 29% | N/A |
#3 | $20.4M | 100 | -16% | $75M |
#4 | $17M | 100 | -17% | $74M |
#5 | $27.3M | 101 | 63% | N/A |